Professor Li Hongjun, Chairman of the Professional Committee of Infectious Disease Radiology of the Chinese Medical Association Radiology Branch and…
Browsing: BioTech
AIM ImmunoTech (NYSE American: AIM, or the Company), an immuno-pharma company focused on the research and development of therapeutics to…
Captiva Verde Land Corp. (CSE: PWR) (OTC: CPIVF) (the “Company” or “Captiva”), is pleased to announce the following updates for…
Just 4 weeks of chiropractic adjustment stimulating proprioception helps people deal with physical pain and annoying dizziness, according to a…
Aptorum Group Limited (“Aptorum Group”), a pharmaceutical company focused on the development of novel therapeutics to address global unmet medical…
1. Targeted by a short seller, China Medical System fought back with…
Holista CollTech (ASX:HCT) (“Holista”) announced today it will co-develop and produce in Malaysia the world’s first nasal sanitising balm using…
Holista將含Path-Away(R)成分的消毒液的分銷範圍擴展至東盟，英國和歐洲 Holista CollTech（ASX代碼：HCT）（以下簡稱“Holista”或本公司）今日宣布，它將在馬來西亞與合作夥伴一起共同研發和生產世界上第一款使用Path-Away®製成的鼻香膏。 Path-Away®是一種基於植物的不含酒精的活性成分，已被證明可以殺死所有先前已知的冠狀病毒，且不會對人造成傷害。 Path-Away®由Global Infection Control Consultants LLC（以下簡稱“ GICC LCC”）研發，該成分已被證明可殺死170多種病原體（包括病毒，細菌和真菌）。它可以殺死艾滋病毒以及極其頑固的結核分枝桿菌。馬來西亞衛生部批准其對H1N1病毒有效。 GICC LLC由其總裁兼首席研究科學家Arthur Martin博士創立，位於南卡羅來納州布盧夫頓。 共同為全球市場研發鼻香消毒膏 Martin博士和Holista創始人兼首席執行官Rajen Manicka博士共同宣布：“Covid-19疫情爆發後，兩家公司將擴大合作夥伴關係，並加快包含Path-Away®鼻香消毒膏的研發。” 兩家公司預計將於2020年第一季度共同申請鼻香消毒膏的全球專利，併計劃於2020年第三季度開始生產，然後在英國和歐洲的冬季開始前將其分銷至全球分銷。 鼻香膏將含有Path-Away®成分，它是由GICC LLC專有的一系列獨立工廠和工藝製成的。…
DNX Biopharmaceuticals, a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of patients with life-long diseases and a resident…
While the world attention is on the fight against Coronavirus in China, Blue Orca is concerned about other things at…
The short-selling company Blue Orca Capital would not have expected that its confrontation with China Medical System Holdings Limited (“China…
AIM ImmunoTech Inc. (NYSE American:AIM) today announced the filing of three provisional patent applications related to its drug candidate Ampligen…
A stiff neck or difficulties swallowing could be caused by spinal degeneration, a new study suggests. Researchers found that changes…
ASX-listed Holista CollTech (ASX:HCT, ‘Holista’) announced today a strong spike in demand in Malaysia for it all-natural disinfectant spray NatShield™…
SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”; stock code: 3681.HK), a Hong Kong-based biopharmaceutical…
IVD Medical Holding Limited (“IVD Medical” or the “Group”), a leading distributor of In Vitro Diagnostic (“IVD”) products in the…
Flagship Product Tauri-Gum(TM) Successfully Listed on Alibaba.com Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating company…
Receives Central Government Funding TOT BIOPHARM International Company Limited (“TOT BIOPHARM” or the “Company”; stock code: 1875.HK) is pleased to…
Viva Biotech Holdings (“Viva Biotech” or the “Company”; stock code: 1873.HK), the world leading operator of a structure-based drug discovery…
EuroEyes International Eye Clinic Limited (“EuroEyes” or the “Company”, stock code: 1846) held the ground-breaking ceremony of its new clinic…